Data-Based Radiation Oncology: Design of Clinical Trials in the Toxicity Biomarkers Era

The ability to stratify patients using a set of biomarkers, which predict that toxicity risk would allow for radiotherapy (RT) modulation and serve as a valuable tool for precision medicine and personalized RT. For patients presenting with tumors with a low risk of recurrence, modifying RT schedules...

Descripción completa

Detalles Bibliográficos
Autores principales: Azria, David, Lapierre, Ariane, Gourgou, Sophie, De Ruysscher, Dirk, Colinge, Jacques, Lambin, Philippe, Brengues, Muriel, Ward, Tim, Bentzen, Søren M., Thierens, Hubert, Rancati, Tiziana, Talbot, Christopher J., Vega, Ana, Kerns, Sarah L., Andreassen, Christian Nicolaj, Chang-Claude, Jenny, West, Catharine M. L., Gill, Corey M., Rosenstein, Barry S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5406456/
https://www.ncbi.nlm.nih.gov/pubmed/28497027
http://dx.doi.org/10.3389/fonc.2017.00083

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5406456/
https://www.ncbi.nlm.nih.gov/pubmed/28497027
http://dx.doi.org/10.3389/fonc.2017.00083

Ejemplares similares